Hyundai Cancer Institute :: Blood and Marrow Transplantation Program
The Hyundai Cancer Institute at CHOC Children’s Blood and Marrow Transplantation (BMT) Program is made up of a team of highly trained oncology experts, including two dedicated nurse coordinators who assist patients and their families through the transplant process. The majority of children who may benefit from a transplant are those with leukemia, including acute lymphoblastic leukemia (ALL) and acute myelogenous leukemia (AML). Other conditions that may respond to transplantation include hematologic disorders such as immune deficiencies and aplastic anemia, Hodgkin’s and non-Hodgkin’s lymphoma, and solid tumors including some brain tumors, Ewing’s sarcoma and neuroblastoma.
The Cancer Institute BMT Program is the only pediatric blood and marrow transplant program in Orange County and offers a full range of transplant procedures and services. In addition to performing all necessary tests and procedures prior to the transplant, we test immediate family members (siblings and parents) to see if they are a match for the patient. (For more information on testing extended family members, please see the Blood or Marrow Transplant Donor FAQs sheet.)
We offer our patients:
Autologous bone marrow transplant
In this transplant, the patient receives his or her own bone marrow.
Allogeneic bone marrow transplant
In this procedure, the bone marrow comes from a person other than the patient. The marrow may come from a related donor (such as a sibling) or an unrelated donor.
Peripheral blood stem cell transplant
In this process, the patient receives his or her own peripheral stem cells (autologous) or stem cells from a related donor (allogeneic).
Umbilical cord blood transplant
In this procedure, blood is collected from the placenta after the umbilical cord is separated from a newborn baby. This blood contains large numbers of bone marrow stem cells and can be used as a source of donor cells from a sibling or unrelated donor for a bone marrow transplant.
BMT Patient and Family Resources
For many, the addition of a blood or marrow transplant to a patient’s treatment roadmap is frightening. To alleviate some of the anxiety and fear about this procedure, the BMT team has put together frequently asked questions and their answers.